Divalproex Sodium
Product Images NDC 70518-3620

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-3620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 01)

Chemical structure of divalproex sodium depicting its polymeric form with sodium ions associated with carboxylate groups and multiple hydrocarbon side chains.*

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 02)

A bar chart comparing percentage values between placebo (PBO) and divalproex sodium (DVPX) across two studies labeled Study 1 (YMRS) and Study 2 (IMRS). The chart shows higher percentages for DVPX compared to PBO in both studies, with 60% vs. 26% in Study 1 and 58% vs. 29% in Study 2.*

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 03)

A cumulative percentage graph comparing Divalproex Sodium and placebo in terms of percentage reduction in CPS rate. The y-axis shows percent reduction from -100% (worsening) to 100% (improvement), while the x-axis represents the percentage of patients. The solid line represents Divalproex Sodium, showing greater improvement compared to the dashed placebo line.*

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 04)

A line graph showing the percent reduction in CPS rate on the vertical axis and the percent of patients on the horizontal axis. Two lines compare high dose (solid line) and low dose (dashed line) treatments, with improvement indicated upwards and worsening downwards.*

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 05)

A bar chart comparing results for Placebo and Divalproex Sodium groups in two separate studies labeled Study 1 and Study 2. The vertical axis shows a numeric scale from 0 to 6. Bars for Placebo are higher than those for Divalproex Sodium in both studies, indicating a comparative measure between the groups.*

FDA Label Image

Mm2 (Divalproex Sodium 250mg 70518 3620 01)

Label for Divalproex Sodium delayed release tablets, 250 mg strength. The label shows a quantity of 1 tablet and includes the labeler name REMEDYREPACK INC. The packaging includes RX only status, NDC number 70518-3620-01, and manufacturer information indicating Unichem, Ghaziabad, India. Additional details include storage instructions and repackager contact information.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Divalproex Sodium 250 mg delayed release tablets, packaged 100 per box. The label shows the product name, dosage strength, dosage form, and quantity. It includes the NDC number 70518-3620-00 and indicates the product is repackaged by RemedyRepack Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.